Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 18, 2008
Is serum hepcidin causative in hemochromatosis? Novel analysis from a liver transplant with hemochromatosisPaul C Adams, Vivian McAlister, Subrata Chakrabarti, et al.
Blood Cells, Molecules & Diseases|September 16, 2003
Expression of ferroportin in hemochromatosis liverPaul C Adams, Yousef P Barbin, Zia A Khan, et al.
Medical Care|January 10, 2012
Effect of ambiguous hemochromatosis gene test results on physician utilizationMark Speechley, David Alter, Helen Guo, et al.
Digestive Diseases and Sciences|December 14, 2011
The impact of population-based screening studies on hemochromatosis screening practicesNatasha Chandok, Mark Speechley, Peter J Ainsworth, et al.
Metabolic Syndrome and Related Disorders|January 16, 2016
Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS StudyJames C Barton, J Clayborn Barton, Paul C Adams, et al.
BMJ Open Diabetes Research & Care|January 12, 2017
Undiagnosed diabetes and impaired fasting glucose in HFE C282Y homozygotes and HFE wild-type controls in the HEIRS StudyJames C Barton, J Clayborn Barton, Paul C Adams, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2018
Apixaban and Rosuvas--tatin Pharmacokinetics in Nonalcoholic Fatty Liver DiseaseRommel G Tirona, Zahra Kassam, Ruth Strapp, et al.
Annals of Hepatology|April 13, 2015
Serum ferritin is a biomarker for liver mortality in the Hemochromatosis and Iron Overload Screening StudyPaul C Adams, James C Barton, Helen Guo, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort StudyEryn Rooney, Gio R Dela Cruz, Terry Ponich, et al.
Pharmacogenetics and Genomics|April 21, 2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel diseaseMohammed Alkhalifa, Gio R Dela Cruz, Terry Ponich, et al.
Pageof 11